A retrospective review of dupilumab and psoriasis biologic combination therapy

Kelly Barrya Tufts University School of Medicine, Boston, MA, USA

Pedro Zancanarob Department of Dermatology, Tufts Medical Center, Boston, MA, USA

Rachel Casseresa Tufts University School of Medicine, Boston, MA, USA

Nicole Dumontb Department of Dermatology, Tufts Medical Center, Boston, MA, USA

David Rosmarinb Department of Dermatology, Tufts Medical Center, Boston, MA, USACorrespondence[email protected]

"A retrospective review of dupilumab and psoriasis biologic combination therapy." Journal of Dermatological Treatment, 32(4), pp. 438–439

Disclosure statement

David Rosmarin has received honoraria as a consultant for AbbVie, Celgene, Dermavant, Dermira, Janssen, Lilly, Novartis, Pfizer, Regeneron, and Sanofi; has received research support from AbbVie, Bristol Meyers Squibb, Celgene, Dermira, Incyte, Janssen, Lilly, Merck, Novartis, Pfizer, and Regeneron Pharmaceuticals Inc; and has served as a paid speaker for AbbVie, Celgene, Janssen, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi. Pedro Zancanaro is the recipient of a Pfizer research grant. All other authors have no conflicts of interest to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A retrospective review of dupilumab and psoriasis biologic combination therapy

Information for

Open access

Opportunities

Help and information

A retrospective review of dupilumab and psoriasis biologic combination therapy

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature